Author: Dyer, Wayne B; Zaunders, John J; Yuan, Fang Fang; Wang, Bin; Learmont, Jennifer C; Geczy, Andrew F; Saksena, Nitin K; McPhee, Dale A; Gorry, Paul R; Sullivan, John S
Title: Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection Document date: 2008_12_11
ID: 0ddutmdd_39
Snippet: The neutralising antibody (NAb) response is another immune mechanism that may contribute to long term control of viraemia [37] . We recently analysed viral replicative fitness and the strength of NAb responses, and confirmed that NAb titres in long-term infected subjects were inversely proportional to viral load. However, NAb titres in SBBC members were comparatively weaker, and in parallel with CTL responses, were highest in those with detectabl.....
Document: The neutralising antibody (NAb) response is another immune mechanism that may contribute to long term control of viraemia [37] . We recently analysed viral replicative fitness and the strength of NAb responses, and confirmed that NAb titres in long-term infected subjects were inversely proportional to viral load. However, NAb titres in SBBC members were comparatively weaker, and in parallel with CTL responses, were highest in those with detectable viraemia. The presence of strong Nabs did not prevent some SBBC members from developing signs of disease progression [38] . Hence, we suggest that while broad Nabs might be generated due to a crippled infection they do not prevent disease progression, particularly in the absence of antiviral helper T cell responses.
Search related documents:
Co phrase search for related documents- cell response and detectable viraemia: 1, 2
- cell response and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell response and immune mechanism: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- cell response and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell response and long term control: 1, 2, 3, 4
- cell response and NAb response: 1, 2, 3, 4
- crippled infection and long term: 1
- CTL response and detectable viraemia: 1, 2, 3, 4
- CTL response and disease progression: 1, 2, 3, 4, 5, 6, 7
- CTL response and disease progression prevent: 1
- CTL response and long term: 1, 2, 3, 4, 5
- detectable viraemia and disease progression: 1, 2, 3, 4, 5
- detectable viraemia and disease progression prevent: 1
- detectable viraemia and long term: 1, 2
- disease progression and immune mechanism: 1, 2, 3, 4, 5, 6, 7, 8, 9
- disease progression and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- disease progression and long term control: 1, 2, 3, 4
- disease progression and NAb response: 1, 2
- disease progression and NAb titre: 1
Co phrase search for related documents, hyperlinks ordered by date